Biophytis Announces Temporary Trading Halt of its Ordinary Shares and Share Warrants on Euronext Growth
PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a...
PARIS and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS) (“Biophytis” or the “Company”), a...
MAINZ, GERMANY, February 10, 2021 (GLOBE NEWSWIRE) - We started the manufacturing process at the Marburg facility with the execution...
Four individuals recognized for their efforts eliminating and raising awareness of preventable patient deaths IRVINE, Calif.--(BUSINESS WIRE)--#PtSafety--The Patient Safety Movement...
Track record of success builds confidence to close treatment gaps for structural heart disease patients ALISO VIEJO, Calif.--(BUSINESS WIRE)--egnite, a...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management is scheduled to participate in the BTIG MedTech and Digital...
LONDON, UK / ACCESSWIRE / February 10, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) announces that it has allotted 7,741,935 new...
VANCOUVER, BC / ACCESSWIRE / February 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to...
Stockholders Are Not Required to Take Any Action at this Time SEATTLE, WA / ACCESSWIRE / February 9, 2021 /...
Toronto, Ontario--(Newsfile Corp. - February 9, 2021) - RF Capital Group Inc. (TSX: RCG) ("RF Capital") today announced that its...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of...
GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting,...
Total Revenues of $42.7 Million, up 11% Year-over-Year; Subscription Revenues of $31.4 Million, up 12% Year-over-Year SAN MATEO, Calif.--(BUSINESS WIRE)--#earnings--Model...
CONCORD, Mass.--(BUSINESS WIRE)--Beta Bionics, Inc., a medical technology company focused on the design, development, and commercialization of the iLet® bionic...
Company Launches Transformation Initiative with Goal of $80 million in Adjusted EBITDA in 2024; Targets Three-Year Average Organic Recurring Revenue...
EDISON, NJ / ACCESSWIRE / February 9, 2021 / Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA)("Hepion"), a clinical stage biopharmaceutical company focused on...
CALGARY, AB / ACCESSWIRE / February 9, 2021 / Asia Green Biotechnology Corp. ("AGB" or the "Company") (CSE:ASIA) is pleased...
VANCOUVER, BC / ACCESSWIRE / February 9, 2021 / Core One Labs Inc. (CSE:COOL)(OTC PINK:CLABF)(Frankfurt::LD62) (WKN: A2P8K3) (the "Company") is...
AirTank Experiences Rapid Growth In Client Roster, Expects More to Come PETERBOROUGH, N.H.--(BUSINESS WIRE)--AirTank, a full-service eCommerce consultancy, announced a...
DURHAM, N.C., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Aerami Therapeutics, Inc. (“Aerami” or the “Company”) a clinical stage biopharmaceutical company...
SAN FRANCISCO, Calif., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Adagene Inc. ("Adagene" or the "Company") (Nasdaq: ADAG), a platform-driven, clinical-stage...